Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

RSG Crossword Tournament helps to celebrate language
2016-07-27

Description: RSG Crossword Tournament  Tags: RSG Crossword Tournament

Dr Annette de Wet (left), Assistant Director
of the Unit for Language Development in
the Centre for Teaching and Learning at
the UFS, Albe Grobbelaar from XWord,
Prof Angelique van Niekerk, Head of the
Department of Afrikaans and Dutch, German
and French, and Prof Lucius Botes, Dean of the
Faculty of the Humanities, during the launch
of the RSG Crossword Tournament.
Photo: Jóhann Thormählen

Sometimes it is difficult for language departments to be topical and to show their relevance for the people out there. However, with the RSG Crossword Tournament, this became possible and Afrikaans could be celebrated in a positive manner. This is what Prof Angelique van Niekerk, Head of the Department of Afrikaans and Dutch, German and French at the University of the Free State (UFS), had to say about this initiative.

Interest during the Vrystaat Arts Festival exceeded all expectations. Altogether, 46 participants from across the country participated on 15 and 16 July 2016. Ilse van Hemert from Pretoria was crowned as the first South African crossword champion.

New dimension to language milieu

Prof Van Niekerk said people are familiar with crossword puzzles from the media, and it was the first time that a tournament like this was presented to the public in South Africa. “This tournament brings something like linguistics and linguistic sensitivity to the fore,” she said. “It is another dimension of the language milieu.” This is exactly why her department would like to see it grow in future.

Wordplay serves as inspiration

The idea for the tournament is based loosely on the film, Wordplay (2006), which is set in New York, and the annual New York Times Crossword Tournament. The South African Tournament was presented in conjunction with the crossword group, XWord, Prof Van Niekerk’s department, and the radio station RSG as brand sponsor.

Crossword puzzles and blockbusters crosswords completed

“This tournament brings something like
linguistics and linguistic sensitivity to
the fore.”


Albe Grobbelaar from XWord said the winners were determined on a points basis. “Competitors had to complete two crossword puzzles and one blockbuster crossword. The difference between the two is that a blockbuster’s clues are within the blocks or grid, but with the crossword, you have white and black blocks with the clues separate on the outside.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept